Andrew Fang

Dr. Andrew Fang

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2022 in Cancer
Verified
Journal Article
Closed access
AFAndrew Fang
Andrew Fang
LSLuke A. Shumaker
Luke A. Shumaker
KMKimberly D. Martin
Kimberly D. Martin
JJJamaal C. Jackson
Jamaal C. Jackson
RFRichard E. Fan
Richard E. Fan
Soroush Rais-BahramiSoroush Rais-Bahrami
Soroush Rais-Bahrami

7 February 2020 in Journal of Robotic Surgery
Verified
Journal Article
Closed access
PDF file
AFAndrew Fang
Andrew Fang
ASAva Saidian
Ava Saidian
CMCristina Magi-Galluzzi
Cristina Magi-Galluzzi
JNJeffrey W. Nix
Jeffrey W. Nix
Soroush Rais-BahramiSoroush Rais-Bahrami
Soroush Rais-Bahrami

28 February 2020 in Journal of Robotic Surgery
Verified
Journal Article
Closed access
PDF file
AFAndrew Fang
Andrew Fang
JRJennifer Rosen
Jennifer Rosen
ASAva Saidian
Ava Saidian
SBSejong Bae
Sejong Bae
FTFabio Y. Tanno
Fabio Y. Tanno
Soroush Rais-BahramiSoroush Rais-Bahrami
Soroush Rais-Bahrami

1 May 2024 in Journal of Endourology
Verified
Journal Article
Closed access
AFAndrew Fang
Andrew Fang
OHOmar Hayek
Omar Hayek
JKJohn Michael Kaylor
John Michael Kaylor
CPCharles C. Peyton
Charles C. Peyton
JFJames E. Ferguson
James E. Ferguson
Soroush Rais-BahramiSoroush Rais-Bahrami
Soroush Rais-Bahrami
Objective: To compare outcomes in patients undergoing robotic-assisted radical cystectomy (RARC) with urinary diversion for bladder cancer with either the single-port (SP) or multiport (MP) robotic platform. Methods: All patients who underwent SP and MP RARC at our institution between January 2018 and January 2023 were retrospectively reviewed. Postoperative analgesia was administered by a departmentwide narcotic stewardship protocol, and inpatient and outpatient narcotic use was tracked. The available preoperative clinical, operative, and postoperative outcomes were analyzed using t -test, chi-square, and Fischer exact statistical measures. Kaplan–Meier analysis with log-rank testing was used to determine the freedom from high-grade (Clavien–Dindo grade ≥3) postoperative complications stratified by SP or MP robotic use. Results: Overall, 96 patients underwent RARC with urinary diversion at our institution, with 49 MP and 47 SP procedures performed. Preoperative clinical parameters including age, body mass index, prior abdominal surgery, and use of neoadjuvant chemotherapy were similar between the two groups. Patients undergoing SP RARC had a shorter operative time (386.0 ± 90.9 minutes vs 453.6 ± 94.8 minutes, p < 0.01) and faster return of bowel function (3.4 ± 1.4 days vs 4.5 ± 2.2 days, p < 0.01). However, both cohorts had similar length of hospitalization, postoperative narcotic use, pathologic staging, and rate of positive surgical margin. Within 3 months postoperatively, both cohorts had a similar high-grade complication, hospital readmission, and cancer recurrence rate. Conclusions: The SP robot allows a safe alternative surgical approach for RARC and offers similar postoperative outcomes compared to the MP robot.

30 January 2022 in The American Surgeon™
Verified
Journal Article
Closed access
AFAndrew Fang
Andrew Fang
JFJessica M. Fazendin
Jessica M. Fazendin
SRSoroush Rais-Bahrami
Soroush Rais-Bahrami
JPJohn R. Porterfield
John R. Porterfield
Background: Single-port (SP) robotic surgery has been utilized in several surgical procedures. We aim to describe our institution’s approach and perioperative experience with SP robotic adrenalectomy and compare it to the traditional multi-port (MP) approach. Methods: We retrospectively reviewed all patients who underwent robotic adrenalectomy by a single surgeon between March 2019 and March 2020. Patient demographic, perioperative factors, and pathologic outcomes were recorded and analyzed using t-tests, chi-square, or Fisher’s exact tests. Results: Thirty-six patients underwent SP (n = 11) and MP (n = 25) robotic adrenalectomy. Age, body mass index, gender, operative time, major Clavien-Dindo complications, and margin status showed no differences. Patients undergoing SP adrenalectomy had a lower estimated blood loss (18.1 ± 13.0 vs 65.6 ± 95.0 cc, P = .02) and smaller lesion size (2.8 ± 1.3 vs 4.1 ± 1.8 cm, P = .04) compared to those undergoing MP. Conclusions: SP adrenalectomy appears to be a feasible approach in select adrenal masses. Further studies are needed to establish its safety and cost effectiveness.

10 June 2021 in Journal of Pediatric Urology
Verified
Journal Article
Closed access
AFAndrew Fang
Andrew Fang
EGElena Gibson
Elena Gibson
RORobert Alan Oster
Robert Alan Oster
Pankaj DanglePankaj Dangle
Pankaj Dangle